Neural pathophysiology of cancer anorexia;Observaciones sobre la patogénesis de la anorexia asociada a cáncer y su regulación por el sistema nervioso central

Nutricion Hospitalaria

Volumn 26, Issue 4, 2011, Pages 677-684

  Sanchez Lara K ^a   Sosa Sanchez R ^a   Green Renner, D ^a   Mendez Sanchez N ^a  

^a LIVER RESEARCH UNIT   (Mexico)

Author keywords

Appetite regulation; Cancer anorexia; Central nervous system

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CYTOKINE; HORMONE;

ANOREXIA; BLOOD; BRAIN; EATING; HUMAN; MALNUTRITION; NEOPLASM; NERVOUS SYSTEM; NUTRITIONAL STATUS; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW;

ANOREXIA; BRAIN; CYTOKINES; EATING; HORMONES; HUMANS; MALNUTRITION; NEOPLASMS; NERVOUS SYSTEM; NEUROTRANSMITTER AGENTS; NUTRITIONAL STATUS;

EID: 79960679522     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2011.26.4.5129     Document Type: Review

References (132)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. International Journal of Cancer 2001; 94: 153-6.
2. Informática. INdEGe. Estadísticas de Mortalidad. 2008.
3. Epidemiología SdSDGd. Compendio de cáncer 2003. Mortalidad. Registro Histopatológico de Neoplasias Malignas.
4. Bossola M, Pacelli F, Tortorelli A, Doglietto GB. Cancer cachexia: it's time for more clinical trials. Ann Surg Oncol 2007; 14: 276-85.
5. Robinson G, Goldstein M, Levine GM. Impact of nutritional status on DRG length of stay. JPEN 1987; 11: 49-51.
6. Van Bokhorst-De van der Schuer, Van Leeuwen PA, Kuik DJ, Klop WM, Sauerwein HP, Snow GB, Quak JJ. The impact of nutritional status on the prognoses of patients with advanced head and neck cancer. Cancer 1999; 86: 519-27.
7. Ferriols Lisart F, Tordera Baviera M. Wasting syndrome in cancer patients: pathophysiology, clinical manifestations and drug therapy. Farm Hosp 2003; 27: 308-16.
8. Sosa-Sánchez R, Sánchez-Lara K, Motola-Kuba D, Green- Renner D. The cachexia-anorexia syndrome among oncological patients. Gac Med Mex 2008; 144: 435-40.
9. Jatoi A Jr, Loprinzi CL. Current management of cancer-associated anorexia and weight loss. Oncology 2001; 15: 497-502.
10. Davis MP, Dickerson D. Cachexia and anorexia: cancer's covert killer. Support Care Cancer 2000; 8: 180-7.
11. Strasser F, Bruera ED. Update on anorexia and cachexia. Hematol Oncol Clin North Am 2002; 16: 589-617.
12. Ramos N. Hambre, saciedad y apetito. Su repercusión en el estado de nutrición de los individuos. Nut Clin 2002; 5: 296-308.
13. Levin BE, Routh VH. Role of the brain in energy balance and obesity. Am J Physiol 1996; 271 (3 Pt 2): R491-500.
14. Kalra SP. Appetite and body weight regulation: is it all in the brain? Neuron 1997; 19: 227-30.
15. Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, Smith MF. Nutritional and metabolic assessment of the hospitalized patient. JPEN 1977; 1: 11-22.
16. Kalra SP, Dube MG, Pu S, Xu B, Horvath TL, Kalra PS. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight. Endocr Rev 1999; 20: 68-100.
17. Kaiyala KJ, Woods SC, Schwartz MW. New model for the regulation of energy balance and adiposity by the central nervous system. Am J Clin Nutr 1995; 62 (5 Suppl.): 1123S-34S.
18. Moschos SJMC. The emerging clinical significance of leptin in humans with absolute or relative leptin deficiency. Curr Opin Endocrinol Diabetes 2005; 12: 332-7.
19. Laviano A, Sanchez-Lara K, Preziosa I, Cascino A, Rossi-Fanelli F. Chronic Renal Failure, Cachexia, and Ghrelin. Int J Pept 2010; 2010, Article ID 648045.
20. Hisadome K Reimann F, Gribble FM, Trapp S. Leptin directly depolarises prepoglucagon neurons in the nucleus tractus solitarius. Diabetes 2010; 59: 1890-8.
21. Arbeiter AK, Buscher R, Petersenn S, Hauffa BP, Mann K, Hoyer PF. Ghrelin and other appetite-regulating hormones in pediatric patients with chronic renal failure during dialysis and following kidney transplantation. Nephrol Dial Transplant 2009; 24: 643-6.
22. Solomon A. Participación del sistema nervioso y del tracto gastrointestinal en la homeostasis energética. Rev Med Univ Navarra 2006; 50: 27-37.
23. Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature 2000; 404: 661-71.
24. Méndez-Sánchez N, Chavez-Tapia NC, Uribe-Esquivel M. Ghrelin and the gastro-hypothalamic axis. Gac Med Mex 2006; 142: 49-58.
25. Milke García M del P. Ghrelin: beyond hunger regulation. Rev Gastroenterol Mex 2005; 70: 465-74.
26. Wang YH, Tache Y, Sheibel AB, Wei JY. Two types of leptinresponsive gastric vagal afferent terminals: an in vitro singleunit study in rats. Am J Physiol 1997; 273: 833-7.
27. Schwartz MW, Seeley RJ, Campfield LA, Burn P Baskin DG. Identification of targets of leptin action in rat hypothalamus. J Clin Inves 1996; 98: 1101-6.
28. Méndez-Sánchez N, Chavez-Tapia N, Uribe M. Effects of Leptin on Biliary Lipids: Potencial Consequences for Gallstone Formation and Therapy in Obesity. Curr Drug Targets Immune Endocr Metab Disord Curr Drug Targets Immune Endocr Metab 2005; 5: 203-8.
29. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Oikawa S. Effects of insulin, leptin and glucagon on ghrelin secretion from isolated perfused rat stomach. Regulatory Peptides 2004; 119: 77-81.
30. Huang L, Li C. Leptin: a multifunctional hormone. Cell Research 2000; 10: 81-92.
31. Doyle P, Rohner-Jeanrenaud F, Jeanrenaud B. Local cerebral glucose utilization in brains of lean and genetically obese (fa/fa) rats. Am J Physiol 1993; 264: E29-36.
32. Tataranni PA, Gautier JF, Chen K, Uecker A, Bandy D, Salbe AD et al. Neuroanatomical correlates of hunger and satiation in humans using positron emission tomography. Proc Natl Acad Sci USA 1999; 96: 4569-74.
33. Moldawer LL, Copeland EM. Proinflammatory cytokines, nutritional support and the cachexia syndrome: interactions and therapeutic options. Cancer 1997; 79: 1828-39.
34. Damasio AR, Tranel D, Damasio H. Individuals with sociopathic behavior caused by frontal damage fail to respond autonomically to social stimuli. Behav Brain Res 1990; 41: 81-94.
35. Dinan T. Psyconeuroendocrinology of mood disorders. Curr Opin Psychiatry 2001; 14: 51-5.
36. Killgore WD, Yurgelun-Todd DA. Developmental changes in the functional brain responses of adolescents to images of high and low-calorie foods. Dev Psychobiol 2005; 47: 377-97.
37. Donelly JK, Kelly HA. Approaching the NHMRC goal for second- dose measles-mumps-rubella vaccine uptake. Med J Aust 1995; 162: 613.
38. Inui A. [Recent development in research and management of cancer anorexia-cachexia syndrome] Abstract. Gan to kagaku ryoho 2005; 32: 743-9.
39. Neary NM, Small CJ, Wren AM et al. Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Met 2004; 89: 2832-6.
40. Von Roenn JH, Knopf K. Anorexia/cachexia in patients with HIV: lessons for the oncologist. Oncology 1996; 10: 1049-56.
41. Bruera E. ABC of palliative care. Anorexia, cachexia, and nutrition. BMJ 1997; 315: 1219-22.
42. Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980; 69: 491-7.
43. Langstein HN, Norton JA. Mechanisms of cancer cachexia. Hematol Oncol Clin North Am 1991; 5: 103-23.
44. Ottery FD. Supportive nutrition to prevent cachexia and improve quality of life. Semin Oncol 1995; 22: 98-111.
45. Haslett PA. Anticytokine approaches to the treatment of anorexia and cachexia. Seminars in Oncology 1998; 25: 53-7.
46. Baracos VE. Regulation of skeletal-muscle-protein turnover in cancer-associated cachexia. Nutrition 2000; 16: 1015-8.
47. Flier JS, Maratos-Flier E. Obesity and the hypothalamus: novel peptides for new pathways. Cell 1998; 92: 437-40.
48. Glare P, Sinclair C, Downing M, Stone P, Maltoni M, Vigano A. Predicting survival in patients with advanced disease. Eur J Cancer 2008; 44: 1146-56.
49. Correia MIaDLW. The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis. Clin Nutr 2003; 22: 235-9.
50. Cardona D. Tratamiento farmacológico de la anorexia-caquexia cancerosa. Nutr Hosp 2006; 21: 17-36.
51. Arrieta O, Michel Ortega RM, Villanueva-Rodríguez G, Serna- Thomé MG, Flores-Estrada D, Diaz-Romero C, et al. Association of nutritional status and serum albumin levels with development of toxicity in patients with advanced non-small cell lung cancer treated with paclitaxel-cisplatin chemotherapy: a prospective study. BMC Cancer 2010; 10: 50.
52. Slaviero KA, Read JA, Clarke SJ, Rivory LP. Baseline nutritional assessment in advanced cancer patients receiving palliative chemotherapy. Nutr Cancer 2003; 46: 148-57.
53. Bossola M, Pacelli F, Doglietto GB. Novel treatments for cancer cachexia. Expert Opin Investig Drugs 2007; 16: 1241-53.
54. Sánchez-Lara K, Sosa-Sánchez R, Green-Renner D, Rodríguez C, Laviano A, Motola-Kuba D et al. Influence of taste disorders on dietary behaviors in cancer patients under chemotherapy. Nutr J 2010; 24 (9): 15.
55. Trant AS, Serin J Douglas HO. Is taste related to anorexia in cancer patients? Am J Clin Nutr 1982; 36: 45-58.
56. Arends J, Bodoky G, Bozzetti F, Fearon K, Muscaritoli M, Selga G et al. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin Nutr 2006; 25: 245-59.
57. Palombine J. Cancer-related weight loss. Clin J Oncol Nurs 2006; 10: 831-2.
58. Palesty JA, Dudrick SJ. What we have learned about cachexia in gastrointestinal cancer. Dig Dis 2003; 21: 198-213.
59. Laviano A RM, Freda F. Neurochemical mechanisms for cancer anorexia. Nutrition 2002; 8: 100-5.
60. Morley JE, Thomas DR, Wilson MM. Cachexia: pathophysiolo - gy and clinical relevance. Am J Clin Nutr 2006; 83: 735-43.
61. Kristensen P, Judge ME, Thim L, Ribel U, Christjansen KN, Wulff BS et al. Hypothalamic CART is a new anorectic peptide regulated by Leptin. Nature 1998; 393: 72-6.
62. Laviano A, Meguid M, Yang Z, Cangiano C, Rossi-Fanelli F. Effects of intra-VMN mianserin and IL-1 on meal number in anorectic tumor-bearing rats. J Invest Med 2000; 48: 40-8.
63. Murry DJ, Riva L, Poplack DG. Impact of nutrition on pharmacokinetics of anti-neoplastic agents. Int J Cancer Suppl 1998; 11: 48-51. 1998; 11: 48-51.
64. Zandio M FM, Cuesta MJ. Neurobiología de la depresión. Anales Sis San Navarra 2002; 25: 43-62.
65. Fekete C, Sarkar S, Rand WM, Harney JW, Emerson CH, Bianco AC et al. Agouti-related protein (AGRP) has a central inhibitory action on the hypothalamic-pituitary-thyroid (HTP) axis; comparisons between the effect of AGRP and neuropeptide Y on energy homeostasis and the HPT axis. Endocrinology 2002; 143: 3846-53.
66. Inui A. Cancer Anorexia-Cachexia Syndrome: are neuropeptides the key? Cancer Res 1999; 59: 4493-501.
67. Mantovani G, Macciò A, Mura L, Massa E, Mudu MC, Mulas C et al. Serum levels of leptin and proinflammatory cytokines in patients with advanced-stage cancer at different sites. J Mol Med 2000; 78: 554-61.
68. Argiles JM, Busquets S, López-Soriano FJ, Figueras M. Pathophysiology of neoplasic cachexia. Nutr Hosp 2006; 21: 4-9.
69. Perboni S, Inui A. Anorexia in cancer: role of feeding-regulatory peptides. Philos Trans R Soc Lond B Biol Sci 2006; 361: 1281-9.
70. Janik JE, Curti BD, Considine RV, Rager HC, Powers GC, Alvord WG et al. Interleukin 1 alpha increases serum leptin concentrations in humans. J Clin Endocrinol Metab 1997; 82: 3084-6.
71. Kurzrock R. The role of cytokines in cancer-related fatigue. Cancer 2001; 92: 1684-8.
72. Meguid MM, Ramos EJ, Laviano A, Varma M, Sato T, Chen C et al. Tumor anorexia: effects on neuropeptide Y and monoamines in paraventricular nucleus. Peptides 2004; 25: 261-6.
73. Makerenko IG, Meguid MM, Gatto L, Chen C, Ugrumov MV. Decreased NPY innervation of the hypothalamic nuclei in rats with cancer anorexia. Brain Res 2003; 961: 100-8.
74. Makarenko IG, Meguid MM, Gatto L, Chen C, Ramos EJ, Goncalves CG, Ugrumov MV. Normalization of hypothalamic serotoin (5-HT 1B) receptor and NPY in cancer anorexia after tumor resection: an immunocytochemical study. Neurosci Lett 2005; 383: 322-7.
75. Ramos EJ, Suzuki S, Meguid MM, Laviano A, Sato T, Chen C et al. Changes in hypothalamic neuropeptide Y and monoaminergic system in tumor-bearing rats: pre and post-tumor resection and at death. Surgery 2004; 136: 270-6.
76. Jatoi A, Loprinzi CL, Sloan JA, Klee GG, Windschitl HE. Neuropeptide Y, leptin and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation. Cancer 2001; 92: 629-33.
77. Ballmer PE, McNurlan MA, Southorn BG, Grant I, Garlick PJ. Effects of human recombinant interleukin-1 beta on protein sysnthesis in rat tissues compared with a classical acute-phase reaction induced by turpentine. Rapid response of muscle to interleukin-1 beta. Bioch J 1991; 279: 683-8.
78. Laviano A, Zhonz-Jin Yang, Gleason JR, Cangiano C, Rossi Fanelli F. Cracking the riddle of cancer anorexia. Nutrition 1996; 12: 707-10.
79. Watkins LR, Goehler LE, Relton JK, Tartaglia N, Silbert L, Martin D et al. Blockade of inerleukin-1 induced hyperthermia by subdiaphragmatic vagotmy: evidence for vagal mediation of immune-brain communication. Neurosci Lett 1995; 183: 27-31.
80. Laviano A, Inui A, Marks DL, Meguid MM, Pichard C, Rossi Fanelli F et al. Neural control of the anorexia-cachexia syndrome. Am J Physiol 2008; 295: E1000-8.
81. López MLC, Tovar S, Kimber W, Gallego R, Virtue S, Blount M, Vázquez MJ, Finer N, Powles TJ et al. Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of thehypothalamus and accumulation of malonyl-CoA. Diabetes 2006; 55: 1327-36.
82. Nagaya N, Ithoh T, Murakami S et al. Treatment of cachexia with ghrelin in patients with COPD. Chest 2005; 128: 1187-93.
83. Nagaya N, Moriya J, Yasumura Y, Uematsu M, Ono F, Shimizu W et al. Effects of ghrelin administration on left ventricular function, exercise capacity and muscle wasting in patients with chronic heart failure. Circulation 2004; 110: 3674-9.
84. Laviano A, Muscaritoli M, Cascino A, Preziosa I, Inui A, Mantovani G, et al. Branched-chain amino acids: the best compromise to achieve anabolism? Current Opinion Clin Nutr Met Care 2005; 8: 408-14.
85. Cangiano C, Cascino A, Ceci F, Laviano A, Mulieri M, Muscaritoli M et al. Plasma and CSF tryptophan in cancer anorexia. J Neural Transmision 1990; 81: 225-33.
86. Macht M. How emotions affect eating: A five-way model. Appetite 2008; 50: 1-11.
87. Kaye WH BU, Wagner A, Frank GK. Brain imaging studies: New insights into puzzling symptoms in anorexia nervosa. Appetite 2007; 49: 272-341.
88. Mark GP, Smith SE, Rada PV, Hoebel BG. An appetitively conditioned taste elicits a preferential increase in mesolimbic dopamine release. Pharmacology, biochemistry, and Behavior 1994; 48: 651-60.
89. Davis JD, Smith GP, Miesner J. Postpyloric stimuli are necessary for the normal control of meal size in real feeding and sham feeding rats. Am J Physiol 1993; 265: R888-95.
90. Edelman MJ, Gandara DR, Meyers FJ, Ishii R, O'Mahony M, Uhrich M et al. Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome. Cancer 1999; 86: 684-8.
91. Brooks SL, Neville AM, Rothwell NJ, Stock MJ, Wilson S. Sympathetic activation of brown-adipose tissue thermogenesis in cachexia. Bioscience Reports 1981; 1: 509-17.
92. Bernstein IL. Neural mediation of food aversions and anorexia induced by tumor necrosis factor and tumor. Neurosci Biohev Res 1996; 177-81.
93. Gidron Y, Perry H, Glennie M. Does the vagus nerve inform the brain about preclinical tumours and modulate them? Lancet Oncol 2005; 6: 245-8.
94. Ávila C AB-LA, Parcet-Ibars MA, VB. Belloch-Ugarte, Campos- Hernández R, Feliu-Tatay C, González-Darder JM. Aplicaciones de la resonancia magnética funcional en pacientes prequirúrgicos: funciones motora, de memoria y lingüística. Rev Neurol 2003; 37: 567-78.
95. Ogawa S, Menon RS, Kim SG, Ugurbil K. On the characteristics of functional magnetic resonance imaging of the brain. Annu Rev Biophys Biomol Struct 1998; 27: 447-74.
96. Wolf-Dieter H HK. Brain receptor imaging. J Nucl Med 2006; 47: 302-12.
97. Pozo M. Neuroimagen funcional: una ventana abierta al funcionamiento del cerebro. Revista de Occidente 2004; 272: 5-23.
98. Uher R, Murphy T, Brammer MJ, Dalgleish T, Phillips ML, Ng VW et al. Medial prefrontal cortex activity associated with symptom provocation in eating disorders. Am J Psychiatry 2004; 161: 1238-46.
99. Frank GK, Bailer UF, Henry S, Wagner A, Kaye WH. Neuroimaging studies in eating disorders. CNS Spectrums 2004; 9: 539-48.
100. Doraiswamy PM, Krishnan KR, Figiel GS, Husain MM, Boyko OB, Rockwell WJ et al. A brain magnetic resonance imaging study of pituitary gland morphology in anorexia nervosa and bulimia. Biol Psychiatry 1990; 28: 110-6.
101. Kornreich L, Shapira A, Horev G, Danziger Y, Tyano S, Mimouni M. CT and MR evaluation of the brain in patients with anorexia nervosa. AJNR 1991; 12: 1213-6.
102. Datlof S, Coleman PD, Forbes GB, Kreipe RE. Ventricular dilation on CAT scans of patients with anorexia nervosa. Am J Psychiatry 1986; 143: 96-8.
103. Krieg JC, Pirke KM, Lauer C, Backmund H. Endocrine, metabolic, and cranial computed tomographic findings in anorexia nervosa. Biol Psychiatry 1988; 23: 377-87.
104. Golden NH, Ashtari M, Kohn MR, Patel M, Jacobson MS, Fletcher A, et al. Reversibility of cerebral ventricular enlargement in anorexia nervosa, demonstrated by quantitative magnetic resonance imaging. J Pediatr1996; 128: 296-301.
105. Ellison Z, Foong J, Howard R, Bullmore E, Williams S, Treasure J. Functional anatomy of calorie fear in anorexia nervosa. Lancet 1998; 352: 1192.
106. Kingston K, Szmukler G, Andrewes D, Tress B, Desmond P. Neuropsychological and structural brain changes in anorexia nervosa before and after refeeding. Psychol Med 1996; 26: 15-28.
107. Maltoni M, Nanni O, Scarpi E, Rossi D, Serra P, Amadori D. High-dose progestins for the treatment of cancer anorexiacachexia syndrome: a systematic review of randomised clinical trials. Ann Oncol 2001; 12: 289-300.
108. McCarthy HD, Crowder RE, Dryden S, Williams G. Megestrol acetate stimulates food and water intake in the rat: effects on regional hypothalamic neuropeptide Y concentrations. Eur J Pharmacol 1994; 265: 99-102.
109. Wigmore SJ, Fearon KC, Maingay JP, Ross JA. Down-regulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci 1997; 92: 215-21.
110. Mazzota P, Jeney CM. Anorexia Cachexia Syndrome: A Systematic Review of the Role of Dietary Polyunsaturated Fatty Acids in the Management of Symptoms, Survival and Quality of life. J Pain Symptom Manage 2009; 37: 1069-77.
111. Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, MacDonald N et al. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol 2004; 22: 2469-76.
112. Guney Y, Ozel Turkcu U, Hicsonmez A, Nalca Andrieu M, Kurtman C. Ghrelin may reduce radiation-induced mucositis and anorexia in head-neck cancer. Med Hypotheses 2007; 68: 538-40.
113. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature 2000; 407: 908-13.
114. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-8.
115. Takaya K, Ariyasu H, Kanamoto N, Iwakura H, Yoshimoto A, Harada M et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Met 2000; 85: 4908-11.
116. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG et al. Ghrelin enhances appetite and increases food intake in humans. The Journal of clinical endocrinology and metabolism 2001; 86: 5992.
117. Dixit VD, Schaffer EM, Pyle RS, Collins GD, Sakthivel SK, Palaniappan R et al. Ghrelin inhibits leptin- and activationinduced proinflammatory cytokine expression by human monocytes and T cells. J Clin Invest 2004; 114: 57-66.
118. Wu R, Dong W, Cui X, Zhou M, Simms HH, Ravikumar T et al. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg 2007; 245: 480-6.
119. Bombski G, Gasiorowska A, Orszulak-Michalak D, Neneman B, Kotynia J, Strzelczyk J et al. Elevated plasma gastrin, CEA and CA 19-9 levles decrease after colorectal resection. Int J Colorectal Dis 2003; 18: 148-52.
120. Shimizu Y, Nagaya N, Isobe T, Imazu M, Okumura H, Hosoda H et al. Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res 2003; 9: 774-8.
121. He YS, Mistry J, Gu J, Hong WK, Xifeng W. Plasma levels of insulin-Like Growth Factor-1 and Lung Cancer Risk: a Case- Control Analysis. J Natl Cancer Inst 1999; 91: 151-6.
122. Weinberg DS, Cavanagh M, Ptichon D, McGlynn K, London W. Cholecystokinin and Gastrin Levels Are Not elevated in Human Pancreatic Adenocarcinoma. Cancer Epidemiol Biomarkers Prev 2001; 10: 721.
123. Chance WT, Van Lammeren FM, Chen MH, Chen WJ, Murphy RF, Joffe SN et al. Plasma and brain cholecystokinin levels in cancer anorexia. J Curg Res 1984: 36: 490-8.
124. Yuzuriha H, Inui A, Asakawa A, Ueno N, Kasuga M, Meguid MM et al. Gastrointestinal hormones (anorexigenic peptide YY and orexigenic ghrelin) influence neural tube development. FASEB J 2007; 21: 2108-12.
125. Bruning PF, Bonfrer JM, Van Noord PA, Hart AA, De Jong- BAkker M, Nooijen WJ. Insulin resistance and breast-cancer risk. In J Cancer 1992; 52: 511-6.
126. Laviano A, Meguid MM, Rossi Fanelli F. Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol 2003;4: 686-94.
127. Inui A. Cancer anorexia-cachexia syndrome: are neuropepetides the key? Cancer Res 1999; 4493-501.
128. Chance WT, Balasubramaniam A, Dayal R, Brown J, Fischer JE. Hypotalamic concentration and release of neuropeptide Y into micodialysates is reduced in anorectic tumor-bearing rats. Life Sciences 1994; 54: 1869-74.
129. Wisse BE, Frayo RS, Schwartz MW, Cummings DE. Reversal of cancer anorexia by blockade of central melanocortin receptors in rats. Endocrinology 2001; 142: 3292-301.
130. McCarthy DO, Daun JM. The effects of cyclooxygenase inhibitors on tumor-induced anorexia in rats. Cancer 1993; 71: 486-74.
131. Meguid MM, Fetissov SO, Varma M, Sato T, Zhang L, Laviano A et al. Hypothalamic dopamine and serotonin in the regulation of food intake. Nutrition 2000; 16: 843-57.
132. Takahashi S, Hakuta M, Aiba K, Ito Y, Horikoshi N, Miura M et al. Elevation of circulating plasma cytokines in cancer patients with high plasma parathyroid hormone-related protein levels. Endocrine-related Cancer 2003; 10: 403-7.